Erick Gamelin
Corporate Officer/Principal at ACRIVON THERAPEUTICS, INC.
Net worth: 150 470 $ as of 29/04/2024
Profile
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
13/05/2024 | 17,765 ( 0.06% ) | 150 470 $ | 29/04/2024 |
Erick Gamelin active positions
Companies | Position | Start |
---|---|---|
ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 02/01/2024 |
Former positions of Erick Gamelin
Companies | Position | End |
---|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | 31/12/2020 |
DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 30/09/2019 |
MACROGENICS, INC. | Corporate Officer/Principal | 28/02/2018 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ACRIVON THERAPEUTICS, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
MACROGENICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Erick Gamelin